查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1674331

东莨菪碱市场依剂型、通路及地区划分

Scopolamine Market, By Dosage Form (Tablet, Syrup, Injection, Patch, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
出版日期: | 出版商: Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球东莨菪碱市场规模估计为 5.162 亿美元，预计到 2032 年将达到 7.974 亿美元，2025 年至 2032 年的复合年增长率为 6.4%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 5.162亿美元
效能资料 从2020年到2024年 预测期 2025年至2032年
预测期：2025-2032年复合年增长率： 6.40% 2032年价值预测 7.974亿美元
数字。 2025年东莨菪碱各地区市场占有率（%）
东莨菪碱市场 - IMG1

东莨菪碱是一种常用于治疗晕动病和噁心的药物化合物。受娱乐性药物使用量增加以及许多终端行业应用不断增长等因素的影响，全球东莨菪碱市场在过去几年中稳步增长。东莨菪碱主要从茄科植物中提取，其中曼陀罗或曼陀罗是其主要商业性来源。它作为脑干和中枢神经系统其他部位的毒蕈碱乙酰胆碱受体的竞争性拮抗剂，阻断影响平衡和运动感知的前庭系统讯号。它有多种剂型——锭剂、贴片和注射剂——可有效控制晕动病、术后噁心呕吐以及癌症化疗相关的噁心等症状。

市场动态：

海上和空中旅行的增加、止吐药消费量的增加以及东莨菪碱贴剂在术后护理中的临床使用增加可能会推动全球东莨菪碱市场的成长。然而，过量服用的副作用以及植物来源提取生物碱的规定可能会阻碍市场成长。正在进行的研究和开发，开发新的草药配方，专注于联合治疗，并评估新的治疗应用，可能为市场相关人员提供机会。原物料价格的波动也会影响市场参与企业的供应和定价策略。

本研究的主要特点

  • 本报告对全球东莨菪碱市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和年复合成长率（CAGR%）。
  • 它还揭示了各个领域的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 它根据公司亮点、产品系列、关键亮点、财务业绩和策略等参数，对全球东莨菪碱市场的主要企业进行了概述。
  • 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球东莨菪碱市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员可以透过用于分析全球东莨菪碱市场的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 主要进展
  • 监管情景
  • 收购与合作场景
  • 资金筹措与投资
  • PEST分析
  • 波特的分析

4. 全球东莨菪碱市场-冠状病毒（COVID-19）大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 市场影响

5. 2020 年至 2032 年全球东莨菪碱市场（以剂型划分）

  • 锭剂
  • 糖浆
  • 注射
  • 修补
  • 其他的

6. 全球东莨菪碱市场（依分销通路划分），2020 年至 2032 年

  • 医院药房
  • 零售药局
  • 网路药局

7. 2020 年至 2032 年全球东莨菪碱市场（按地区）

  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第八章竞争格局

  • 公司简介
    • Alchem International
    • Integra LifeSciences Holding Corporation
    • Alkaloids Corporation
    • Boehringer Ingelheim
    • Caleb Pharmaceuticals, Inc.
    • Centroflora Group
    • Fine Chemicals Corporation
    • GlaxoSmithKline plc
    • Henan Fusen Pharmaceutical Co., Ltd.
    • Laboratorio RAAM de Sahuayo
    • Mylan NV（part of Viatris）
    • Novartis AG
    • Pfizer Inc.
    • Pharmaceutical Associates, Inc.
    • Phytex Australia
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
    • Global Alkaloids

第九章分析师建议

  • 机会
  • 分析师观点
  • Coherent Opportunity Map

第十章参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI1965

Global Scopolamine Market is estimated to be valued at USD 516.2 Mn in 2025 and is expected to reach USD 797.4 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 516.2 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.40% 2032 Value Projection: USD 797.4 Mn
Figure. Scopolamine Market Share (%), By Region 2025
Scopolamine Market - IMG1

Scopolamine is a pharmaceutical compound that is commonly used to curb motion sickness and nausea. Global scopolamine market has witnessed steady growth over the past few due to factors such as increasing recreational drug usage and rising application across numerous end-use industries. Scopolamine is predominantly extracted from plants belonging to the Solanaceae family of which Datura stramonium or Jimson weed is the major commercial source. It acts as a competitive antagonist of muscarinic acetylcholine receptors in the brainstem and other parts of the central nervous system to block signals from the vestibular system affecting balance and motion perception. The drug is available in various dosage forms including tablets, patches, and injections to effectively manage symptoms of motion sickness, post-operative nausea & vomiting, and nausea associated with cancer chemotherapy.

Market Dynamics:

Rising sea and air travel, increasing consumption of antiemetic drugs, and growing clinical use of scopolamine patches for postoperative care can drive the global scopolamine market growth. However, adverse effects associated with overdosage and restrictions on plant-derived alkaloids extraction can hamper the market growth. Ongoing R&D to develop new galenic formulations, focus on combination therapies, and evaluation of additional therapeutic applications can offer opportunities for market players. Fluctuating prices of raw materials also impact the supply and pricing strategies adopted by different market participants.

Key Features of the Study:

  • This report provides in-depth analysis of the global scopolamine market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global scopolamine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Pfizer, Baxter, Caleb Pharmaceuticals, Alkaloids of Australia.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global scopolamine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global scopolamine market.

Detailed Segmentation-

  • By Dosage Form:
    • Tablet
    • Syrup
    • Injection
    • Patch
    • Others
  • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Alchem International
    • Integra LifeSciences Holding Corporation
    • Alkaloids Corporation
    • Boehringer Ingelheim
    • Caleb Pharmaceuticals, Inc.
    • Centroflora Group
    • Fine Chemicals Corporation
    • GlaxoSmithKline plc
    • Henan Fusen Pharmaceutical Co., Ltd.
    • Laboratorio RAAM de Sahuayo
    • Mylan N.V. (part of Viatris)
    • Novartis AG
    • Pfizer Inc.
    • Pharmaceutical Associates, Inc.
    • Phytex Australia
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
    • Global Alkaloids

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Dosage Form
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Scopolamine Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Scopolamine Market, By Dosage Form, 2020 - 2032, (USD Mn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Tablet
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Syrup
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Injection
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Patch
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Scopolamine Market, By Distribution Channel, 2020 - 2032, (USD Mn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Hospital Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Retail Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Online Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Scopolamine Market, By Region, 2020 - 2032, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Mn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Company Profiles
    • Alchem International
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Integra LifeSciences Holding Corporation
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Alkaloids Corporation
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Boehringer Ingelheim
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Caleb Pharmaceuticals, Inc.
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Centroflora Group
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Fine Chemicals Corporation
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GlaxoSmithKline plc
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Henan Fusen Pharmaceutical Co., Ltd.
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Laboratorio RAAM de Sahuayo
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Mylan N.V. (part of Viatris)
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Novartis AG
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Pfizer Inc.
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Pharmaceutical Associates, Inc.
    • Phytex Australia
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
    • Global Alkaloids

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About Us and Sales Contact